Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand
about
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosisPartial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addictionRTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNSProgesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitisSuppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination.Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOGA promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.Characterization of human platelet binding of recombinant T cell receptor ligand.RTL therapy for multiple sclerosis: a Phase I clinical study.Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats.Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.Effective Arrestin-Specific Immunotherapy of Experimental Autoimmune Uveitis with RTL: A Prospect for Treatment of Human Uveitis.A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell toleranceA novel HLA-DRα1-MOG-35-55 construct treats experimental strokeAntigen-specific immunotherapy of autoimmune and allergic diseasesPeptide-MHC-based nanovaccines for the treatment of autoimmunity: a "one size fits all" approach?Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes
P2860
Q26824619-52691246-66FA-4EBA-882E-03B91E90EC77Q28486981-4C5BFCD9-9384-43EA-9B18-46459C5069E4Q28742932-AA64BFA7-9D05-4DD6-8693-44BA28660C96Q33716702-8EAE840B-C5E5-4774-BF5D-080056194C58Q33727390-29351F6B-6A55-4473-AFBE-2AB3E71B5E75Q33838187-BE7E9D98-858F-4593-ACAE-1894E52725B1Q33928060-F0F65660-86BD-49CA-9B9F-2BA9A1189404Q34077153-7B9EAF1E-47DA-49FE-ABB1-26F09AC34D14Q34350992-ABE244C7-9522-4F64-8796-41017E52917BQ34520672-0C5CB3AE-749A-4F54-84E7-33FD726672C2Q35637379-E02E18AA-1D0B-426F-8478-C2526805A427Q35893543-DF36CDE4-BCD8-4E2C-920A-D60CC4EF3CCAQ36231789-749BD403-7B55-4375-9947-FD973B183D66Q36252781-AE2BAF79-DDF8-4902-B22A-93DF1D1FF404Q37149410-35098954-5675-443D-8640-EE9404C3D75BQ37212157-A4FDA466-1296-4251-8058-8DA2C0ACD9BAQ37684577-F7825D9D-DADF-465C-B38A-320A7CE88189Q37790023-06BD3088-CC1C-4853-B71F-F25BC4191709Q37866131-1946D846-A4A1-4E70-AC92-E80D771E8FE9Q38837294-F620768E-FE88-46B9-BFD0-DB43D674604CQ41549575-FF9C2232-9BCE-40FC-BB06-697A76E05604Q42724811-942632A2-35CA-48E3-8E1B-AEF99383F609
P2860
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokine switch and bystander ...... mbinant T-cell receptor ligand
@en
Cytokine switch and bystander ...... binant T-cell receptor ligand.
@nl
type
label
Cytokine switch and bystander ...... mbinant T-cell receptor ligand
@en
Cytokine switch and bystander ...... binant T-cell receptor ligand.
@nl
prefLabel
Cytokine switch and bystander ...... mbinant T-cell receptor ligand
@en
Cytokine switch and bystander ...... binant T-cell receptor ligand.
@nl
P2093
P2860
P1476
Cytokine switch and bystander ...... mbinant T-cell receptor ligand
@en
P2093
Arthur A Vandenbark
Chris Roberts
Gregory G Burrows
Halina Offner
Lisa Miller
Sandhya Subramanian
Sushmita Sinha
Thomas M Proctor
P2860
P304
P356
10.1523/JNEUROSCI.5812-08.2009
P407
P577
2009-03-01T00:00:00Z